Cipla Update by Epic Research

Licenses rights for innovative product



Grants Salix Pharma rights to Rifaximin complex patents



Cipla says rights to Salix Pharma exclude Asia and Africa



Real Time News & Trading Trends Keep Liking #EpicResearch




Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+



For more information ✆ – 0731-6642300 or Visit http://ift.tt/1k8NnLH

Posted in: Indian Market Tips